GAGA Share Market News

[hfe_template id='11223'] [ad_1] Shares of Indian pharmaceutical companies, including Aurobindo Pharma, Laurus Labs, IPCA Laboratories, and Lupin, dropped as much as 7% on Friday after U.S. President Donald Trump signaled that tariffs on the sector were imminent. Speaking to reporters aboard Air Force One, Trump stated that his administration was evaluating potential tariffs on pharmaceuticals. “Pharma is going to start coming in at, I think, a level that you haven’t really seen before,” he said, hinting at forthcoming trade measures. He further clarified that pharmaceuticals were being considered as a separate category for tariffs, with an announcement expected soon. “We are looking at pharma as a separate category. We will be announcing that sometime in the near future—not in the distant future,” he added. The remarks come just a day after pharma stocks had rallied on expectations that the sector would be spared from trade restrictions. On Thursday, the Nifty Pharma in...

[hfe_template id='11223'] [ad_1] Indian pharmaceutical stocks fell up to 3% on the BSE on Thursday amid fears of tariffs by US President Donald Trump, with a fresh setback from the announcements in the auto sector having a rub-off impact. Shares of Aurobindo Pharmaceuticals fell 2% to their day’s low of Rs 1,132.75 while those of Ipca Laboratories went down by 2.7% to Rs 1,403.95. Sun Pharmaceuticals and Dr Reddy’s Laboratories shares tumbled 1.7% each and Ajanta Pharma shares slid by 2.5%. Meanwhile, the shares of Zydus Lifesciences, Alkem Laboratories, Lupin, and Natco Pharma were trading lower between 1% and 1.5% around 10:20 am. Speaking to reporters at the White House, Trump, in a previous speech, said the United States would need all those products if there were problems including wars. "We've been ripped off by every country," Trump said as he presided over a meeting of his Cabinet. Live Events Commerce Secretary Howard Lutnick, during the same meeti...

[hfe_template id='11223'] [ad_1] In a highly volatile trading session today, benchmark indices Nifty and Sensex extended their losing streak to a fifth day, weighed down by IT and realty stocks. The market was trading in red throughout the day. By noon, the Sensex had slipped 420 points, or 0.5%, to 78,792, while the Nifty was down 112 points, or 0.5%, trading at 23,839. In such a market, analyst Sudeep Shah, Deputy Vice President and Head of Technical & Derivatives Research at SBI Securities, suggests how one should trade stocks that were in focus in the previous trading sessions based on derivative and technical data. Nifty Pharma index surges nearly 2%, Ipca Laboratories rebounds strongly from 100-day EMA On Thursday, Nifty Pharma gave a consolidation breakout and it has strongly outperformed frontline indices. Among the constituents of the Pharma index, the majority of the stocks have ended on a positive note. The stock of Ipca Laboratories was the best-performin...

[hfe_template id='11223'] [ad_1] Shares of PFC are likely to remain in focus today as the company is nearing its ex-date, i.e, November 25 for the purpose of its interim dividend of Rs 3.5 per share, which was declared earlier this month. “We would like to inform you that, the Board of Directors of Power Finance Corporation Ltd. in its meeting held today i.e. 08. 11.2024 have inter alia considered and approved the following: Declaration of 2nd interim dividend @ Rs.3.50/-(Rupees Three and fifty paisa only) per equity share (i.e. @ 35%) (subject to deduction of TDS) on the face value of the paid-up equity shares of {10/- each for the FY 2024-25,” said the company in a filing to the exchanges. The company had fixed November 25 as the record date for the purpose and announced that the said dividend will be paid to the shareholders on or before December 8. After implementation of the T+1 framework, the record date and ex-date are the same in most cases unless there is a mark...

[hfe_template id='11223'] [ad_1] IRFC Share Price 140.35 12:01 PM | 14 Nov 2024 0.73(0.53%) Suzlon Energy Share Price 56.73 12:01 PM | 14 Nov 2024 2.7(5.0%) IREDA Share Price 191.66 12:01 PM | 14 Nov 2024 4.07(2.17%) Tata Motors Share Price 776.9 12:01 PM | 14 Nov 2024 -9.36(-1.19%) YES Bank Share Price 19.41 12:01 PM | 14 Nov 2024 0.34(1.79%) HDFC Bank Share Price 1696.7 12:01 PM | 14 Nov 2024 15.36(0.92%) NHPC Share Price 77.49 12:01 PM | 14 Nov 2024 -0.46(-0.58%) RVNL Share Price 422.5 12:01 PM | 14 Nov 2024 2.65(0.64%) SBI Share Price 807.0 12:01 PM | 14 Nov 2024 -1.65(-0.21%) Tata Power Share Price 405.0 12:01 PM | 14 Nov 2024 5.65(1.42%) Tata Steel Share Price 138.26 12:01 PM | 14 Nov 2024 -0.91(-0.66%) Adani Power Share Price 556.9 12:01 PM | 14 Nov 2024 9.9(1.81%) PayTM Share Price 787.3 12:01 PM | 14 Nov 2024 34.05(4.53%) PNB Share Price 101.5 12:01 PM | 14 Nov 2024 0.94(0.94%) Zomato Share Price 268.17 12:01 PM | 14 Nov 2024 9.78(3.79%) BEL Share Price 281.05 1...

[hfe_template id='11223'] [ad_1] Synopsis Ipca Laboratories Ltd hit a fresh record high in October 2024, breaking a 2-week consolidation. Experts suggest the rally may continue, with short-term traders targeting Rs 1,650-1,680 in 1-2 months. The stock has been on an upward trend, trading above key moving averages. Traders are encouraged to buy, with a stop loss below Rs 1,450. Ipca Laboratories Ltd, part of the pharma space, broke a 2-week consolidation to hit a fresh record high in October 2024 and chart pattern suggests that the rally may not be over yet.Short-term traders can look to buy for a target of Rs 1,650-1,680 in the next 1-2 months, suggest experts.The pharma stock has rallied more than 30% in the last 3 months. The momentum helped the stock to breakout from the 2-week consolidation seen on the daily BY ETMarkets.com Oct 11, 2024, 10:00:00 AM IST Gift A Story Share member-only stories with your friends or family and help them read it for free. Gifting Limit R...